Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory... Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory approval and increase patient access to medicines. The group has a business presence in the United States, EMEA and other regions, of which a majority of revenue is derived from the United States. 詳細を表示
Full-Year 2024 Revenue of $384.4 million, Bookings of $445.3 millionConfirms Adjusted EBITDA within Guidance Range of $120 million to $124 million RADNOR, Pa., Jan. 15, 2025 (GLOBE NEWSWIRE...
RADNOR, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the...
RADNOR, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today showcases its impact on research by celebrating more than...
RADNOR, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of...
RADNOR, Pa., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.84 | 7.76340110906 | 10.82 | 12.21 | 10.46 | 1093228 | 11.36210725 | CS |
4 | 1.12 | 10.6261859583 | 10.54 | 12.21 | 10.3 | 1045819 | 11.00916497 | CS |
12 | 1.48 | 14.5383104126 | 10.18 | 12.21 | 9.41 | 1196228 | 10.8572865 | CS |
26 | -4.7 | -28.728606357 | 16.36 | 16.93 | 9.41 | 1172593 | 11.44458191 | CS |
52 | -4.08 | -25.9212198221 | 15.74 | 19.8702 | 9.41 | 871679 | 13.07375989 | CS |
156 | -15.78 | -57.5072886297 | 27.44 | 28.62 | 9.41 | 847427 | 16.89096168 | CS |
260 | -23.35 | -66.6952299343 | 35.01 | 45.48 | 9.41 | 830111 | 20.59924532 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約